Both in Surgical Instruments
Neuropace vs MiMedx Group
Over the past year NPCE returned +41.9% and MDXG returned −58.4%; their daily moves had a correlation of 0.24.
NPCE +41.9% MDXG −58.4%Growth of $1, one year, split-adjusted
| Metric | NPCE | MDXG |
|---|---|---|
| Price | $13.34 | $3.20 |
| Market cap | $457.9M | $467.0M |
| Today | +8.37% | −1.54% |
| 1 month | +5.3% | −30.7% |
| 6 months | −26.4% | −12.6% |
| Year to date | −13.6% | −52.7% |
| 1 year | +41.9% | −57.4% |
| Revenue growth (YoY) | +17.1% | −45.2% |
| Gross margin | 82.8% | 79.8% |
| Net margin | −27.2% | −13.9% |
| P/E (TTM) | — | — |
| Price / sales | 4.6× | 1.5× |
| Net cash | -$7.3M | $120.8M |
| Dividend yield | — | — |
| Volatility (60d) | 43.5% | 51.7% |
| Short % of float | 3.7% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).